Literature DB >> 30396370

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Giovanni Orsolini1, Giovanni Adami2, Maurizio Rossini2, Angelo Fassio2, Alessandro Giollo2, Cristian Caimmi2, Luca Idolazzi2, Davide Gatti2, Ombretta Viapiana2.   

Abstract

Following publication of the original article [1], the authors reported a typesetting error.

Entities:  

Year:  2018        PMID: 30396370      PMCID: PMC6235198          DOI: 10.1186/s13075-018-1753-2

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


Correction

Following publication of the original article [1], the authors reported a typesetting error. The author’s given names and family names have been inverted. The correct author panel is as follows: Given name: Giovanni, Family name: Orsolini Given name: Giovanni, Family name: Adami Given name: Maurizio, Family name: Rossini Given name: Angelo, Family name: Fassio Given name: Alessandro, Family name: Giollo Given name: Cristian, Family name: Caimmi Given name: Luca, Family name: Idolazzi Given name: Davide, Family name: Gatti Given name: Ombretta, Family name: Viapiana The publishers apologise for this error. The original article [1] has been corrected.
  1 in total

1.  Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Authors:  Giovanni Orsolini; Giovanni Adami; Maurizio Rossini; Angelo Fassio; Alessandro Giollo; Cristian Caimmi; Luca Idolazzi; Davide Gatti; Ombretta Viapiana
Journal:  Arthritis Res Ther       Date:  2018-10-18       Impact factor: 5.156

  1 in total
  1 in total

1.  Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.

Authors:  Ye Zhang; Ming-Wei Liu; Yun He; Ning Deng; Yan Chen; Jiecong Huang; Wei Xie
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.